RxDoctor Payments Data

Jonathan Lam, PA

Medical · Seattle, WANPI 1720540867

Payments from drug & device makers

$2,533in general payments, 2019–2025

Across 41 payments — averaging $61.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Stimwave Technologies Incorporated$51
  • Medtronic$50
  • Nevro Corp.$42
  • Collegium Pharmaceutical, Inc.$41
  • Lilly USA, LLC$38
  • plus $14 from 1 others

What the payments were for

  • Travel & lodging$1,18747%
  • Food & beverage$1,34653%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,533 in reported general payments places this provider in the 85th percentile of 457 medical providers in Washington.

See all medical providers in Washington

Medicare billing

Part B allowed, 2024
$20,330
Medicare patients
96
Services billed
371

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine16$4,428
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl26$3,028
Oxycodone Hcl39$757
Pregabalin14$463
Duloxetine Hcl26$385
Tizanidine Hcl20$163
Memantine Hcl11$145

Paid to pharmacies, not to this prescriber.

Other medical in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →